Gapping down
In reaction to earnings/guidance:
- GDRX -32.9% (also authorizes new $250 mln share repurchase program), SEER -19.4%, AMBA -17.7%, BIGC -17.6%, VRM -15.3%, HRTX -12.7%, LCID -12.5% (also signs agreements for a full production factory in Saudi Arabia), PUBM -11.9%, GRPN -11.1%, EHTH -9.9%, SE -8.6%, VLDR -8.4%, GOEV -7.7%, NVAX -7% (also shares Phase 3 data on NVX-CoV2373), FOUR -6.6%, TREX -6.4%, SUPN -6.1%, PGNY -6%, SDC -5.5%, ACAD -5.5%, ENDP -5.1%, ZM -3.3% (also authorizes new $1 bln share repurchase program), OKE -2.7%, KD -2.3%, RKLB -2%, FGEN -1.9%, HPQ -1.9%, SJM -1.4%, SBAC -1.1%
Other news:
- OZON -19% (comments on impact of U.S., EU and other sanctions on its operations )
- NTLA -6.9% (NLTA and REGN announce interim data from Phase 1 study of NTLA-2001)
- FOUR -4.8% (will acquire both Finaro and The Giving Block)
- AES -3.4% (files mixed securities shelf offering)
- XPEV -2.6% (delivered 6,225 Smart EVs in February 2022, representing a 180% increase yr/yr)
- NIO -2.4% (provides February 2022 delivery update )
- HBAN -2.3% (to acquire Capstone Partners)
- THC -1.7% (will no longer pursue a spinoff of its Conifer Health Solutions subsidiary; reaffirms guidance; will host call at 10 a.m. ET )
- TTE -1.6% (will no longer provide capital for new projects in Russia)
Analyst comments:
- IONS -3.2% (initiated with a Sell at Citigroup )
- HEAR -2.8% (downgraded to Neutral from Outperform at Wedbush)
- WIX -1.5% (downgraded to Neutral from Overweight at Atlantic Equities)
- CMCSA -1% (downgraded to Hold from Buy at Truist)
Gapping up
In reaction to earnings/guidance:
- DDD +13.4%, TASK +10.9%, TGT +10.9%, SAIL +9.6%, WDAY +7.4%, ADT +7%, EVRI +5.3%, APPF +5.2%, AZO +5.2%, AMRS +4.2%, BIDU +4%, BLDR +3.4%, STRL +3.3%, PRGO +2.8%, KSS +2.5%, NKTR +2.3%, DAR +2.2%, TWNK +1.7%, HGV +1.6%, FRPT +1.5%, AMRN +1.2%, HRL +1%
Other news:
- CTIC +61.6% (announces FDA accelerated approval of VONJO for the treatment of adult patients with myelofibrosis and thrombocytopenia )
- ACI +8.9% (commences review of potential strategic alternatives)
- DRIO +8.9% (enters into strategic multi-year $30 mln agreement with Sanofi (SNY))
- LEGN +7.3% (CARVYKTI BCMA-Directed CAR-T therapy, receives U.S. FDA approval for the treatment of adult patients with relapsed or refractory multiple myeloma)
- BITF +6.9% (Provides February 2022 Production and Mining Operations Update)
- VALN +3.9% (receives emergency use authorization from bahrain for its inactivated COVID-19 vaccine VLA2001)
- LDOS +3.5% (wins Defense Enclave Services contract)
- EGY +2% (provides update on Etame field reconfiguration and FSO Deployment)
- STLD +1.9% (increases dividend; also authorizes additional share repurchase program of up to $1.25 bln)
- AZN +1.5% (and Neurimmune close exclusive global collaboration and licence agreement to develop and commercialise NI006)
- APP +1.4% (to acquire Wurl for $430 mln; also authorizes new $750 mln share repurchase program)
- CVX +1.2% (executing plans to deliver higher returns and lower carbon; Raises share buyback guidance)
Analyst comments:
- TSHA +5% (initiated with an Overweight at Wells Fargo)
- RVMD +3.8% (upgraded to Buy from Hold at Stifel)
- NXTC +3.3% (initiated with a Buy at Ladenburg Thalmann)
- SDGR +1.6% (initiated with a Buy at Citigroup)
- LOGI +1.5% (upgraded to Outperform from Neutral at Wedbush)
Early premarket gappers
- Gapping up:
- CTIC +29.5%, LEGN +19.2%, DDD +11.2%, TASK +10.9%, SAIL +9.6%, ACI +8.9%, WDAY +6.7%, APPF +5.2%, VALN +4.5%, LDOS +3.5%, STRL +3.3%, NKTR +2.3%, DAR +2.2%, STLD +1.9%, CVX +1.7%, FRPT +1.5%, APP +1.4%, EGY +1.2%, AZN +1%
- Gapping down:
- GDRX -32.3%, SEER -19.4%, OZON -19%, AMBA -17.7%, BIGC -16.1%, HRTX -15.1%, VRM -14.3%, FGEN -14%, LCID -12.9%, GRPN -11.1%, PUBM -11%, NTLA -8.4%, NVAX -7%, SDC -6.8%, TREX -6.4%, SUPN -6.1%, PGNY -6%, ACAD -5.5%, VLDR -5.4%, ENDP -3.9%, AES -3.4%, GOEV -3.3%, ZM -3.1%, OKE -2.7%, XPEV -2.6%, BP -2.5%, TTE -2.3%, KD -2.3%, NIO -2.2%, LAZR -1.7%, HPQ -1.6%, SHEL -1.1%, SBAC -1.1%
Research Calls I
- Upgrades:
- Advanced Drainage Systems (WMS) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $145
- Amedisys (AMED) upgraded to Neutral from Sell at UBS; tgt $168
- Farfetch (FTCH) upgraded to Hold from Sell at Societe Generale; tgt lowered to $23
- Jack Henry (JKHY) upgraded to Outperform from Perform at Oppenheimer; tgt $206
- Kroger (KR) upgraded to Outperform from Market Perform at Telsey Advisory Group; tgt raised to $54
- Lennox Int'l (LII) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt $271
- Logitech Int'l SA (LOGI) upgraded to Outperform from Neutral at Wedbush; tgt $90
- Quanta Services (PWR) upgraded to Buy from Neutral at B. Riley Securities; tgt raised to $129
- Revolution Medicines (RVMD) upgraded to Buy from Hold at Stifel; tgt lowered to $26
- Sunstone Hotel (SHO) upgraded to Outperform from In-line at Evercore ISI
- Downgrades:
- Ameriprise Financial (AMP) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $325
- BP Midstream (BPMP) downgraded to Sell from Neutral at Citigroup; tgt $16
- Comcast (CMCSA) downgraded to Hold from Buy at Truist
- Foot Locker (FL) downgraded to Neutral from Buy at B. Riley Securities; tgt $34
- Foot Locker (FL) downgraded to Underweight from Overweight at Barclays; tgt lowered to $24
- Foot Locker (FL) downgraded to Neutral from Buy at Goldman; tgt lowered to $35
- Galiano Gold (GAU) downgraded to Hold from Buy at Berenberg (yesterday)
- GoodRx (GDRX) downgraded to Market Perform from Outperform at Cowen; tgt lowered to $22
- GoodRx (GDRX) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $27
- Lincoln National (LNC) downgraded to Neutral from Buy at Goldman; tgt $74
- ON24, Inc. (ONTF) downgraded to Mkt Perform from Outperform at William Blair
- ON24, Inc. (ONTF) downgraded to Neutral from Outperform at Robert W. Baird; tgt $18
- ON24, Inc. (ONTF) downgraded to Neutral from Overweight at Piper Sandler; tgt $17
- Pennant Group (PNTG) downgraded to Hold from Buy at Stifel; tgt lowered to $18
- Sunstone Hotel (SHO) downgraded to Underweight from Overweight at Barclays; tgt lowered to $11
- Turtle Beach (HEAR) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $24
- Viatris (VTRS) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $13
- Viatris (VTRS) downgraded to Mkt Perform from Outperform at Raymond James
- Voya Financial (VOYA) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $74
- Vroom (VRM) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $6
- Wix.com (WIX) downgraded to Neutral from Overweight at Atlantic Equities; tgt $100
- Others:
- Alnylam Pharma (ALNY) initiated with a Buy at Citigroup; tgt $223
- Ameresco (AMRC) resumed with a Buy at Guggenheim; tgt $80
- America First Multifamily Investors, L.P. (ATAX) initiated with a Mkt Outperform at JMP Securities; tgt $7
- Arcellx (ACLX) initiated with a Buy at BofA Securities; tgt $24
- Ascendis Pharma (ASND) initiated with a Buy at Citigroup; tgt $187
- Blueprint Medicines (BPMC) initiated with a Neutral at Citigroup; tgt $71
- Constellation Energy (CEG) initiated with a Neutral at Mizuho; tgt $46
- Criteo (CRTO) initiated with a Buy at The Benchmark Company; tgt $45
- DZS Inc. (DZSI) resumed with a Buy at Stifel; tgt $20
- Ionis Pharma (IONS) initiated with a Sell at Citigroup; tgt $26
- Meta Platforms (FB) initiated with a Hold at The Benchmark Company
- MongoDB (MDB) initiated with an Outperform at RBC Capital Mkts; tgt $505
- NextCure (NXTC) initiated with a Buy at Ladenburg Thalmann; tgt $16
- Onconova Therapeutics (ONTX) initiated with a Buy at Ladenburg Thalmann; tgt $7
- Pinterest (PINS) initiated with a Hold at The Benchmark Company
- Schrodinger (SDGR) initiated with a Buy at Citigroup; tgt $55
- Silver Spike Investment Corp. (SSIC) initiated with an Overweight at Piper Sandler; tgt $17
- Silver Spike Investment Corp. (SSIC) initiated with a Hold at Stifel; tgt $14
- Snap (SNAP) initiated with a Buy at The Benchmark Company; tgt $50
- Taysha Gene Therapies (TSHA) initiated with an Overweight at Wells Fargo; tgt $25
- The Trade Desk (TTD) initiated with a Hold at The Benchmark Company
- Twitter (TWTR) initiated with a Hold at The Benchmark Company
After Hours Summary: Busy earnings session, DDD +13.2%, SAIL +10.5%, WDAY +7% higher on earnings; GDRX -27.6%, AMBA -18.5%, BIGC -17.6%, LCID -13.4%, PUBM -10.4%, GRPN -8.7% lower on earningsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: DDD +13.2%, TASK +10.7%, SAIL +10.5%, WDAY +7%, STRL +5.5%, NKTR +2.3%, RKLB +1.5%, DAR +1.1%, OSH +0.4%
Companies trading higher in after hours in reaction to news: ACI +9% (commences review of potential strategic alternatives), LDOS +2.1% (wins Defense Enclave Services contract), APP +1.4% (to acquire Wurl for $430 mln; also authorizes new $750 mln share repurchase program), EHC +0.8% (provides update regarding Board refreshment and separation of Enhabit), STLD +0.7% (increases dividend; also authorizes additional share repurchase program of up to $1.25 bln), EAF +0.1% (CEO to retire)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: GDRX -27.6% (also authorizes new $250 mln share repurchase program), AMBA -18.5%, BIGC -17.6%, HRTX -15.6%, LCID -13.4% (also signs agreements for a full production factory in Saudi Arabia), GOEV -11.5%, SUPN -10.8%, PUBM -10.4%, GRPN -8.7%, SEER -8.6%, VRM -7.1%, ENDP -6.8%, TREX -6%, FGEN -5.5%, SDC -5.5%, NVAX -5.2% (also shares Phase 3 data on NVX-CoV2373), ACAD -4.8%, ZM -2.4% (also authorizes new $1 bln share repurchase program), KD -2.3%, OKE -2%, HPQ -1.2%, SBAC -1.1%, PGNY -1%, LAZR -0.4%, AMRC -0.3%, SRI -0.2%
Companies trading lower in after hours in reaction to news: NTLA -7.9% (NLTA and REGN announce interim data from Phase 1 study of NTLA-2001), DTM -3% (approves repurchase up to 125K shares to offset stock-based comp program), JBLU -0.8% (files mixed securities shelf offering), BP -0.2% (weighing sale of roughly 20% stake in Rosneft back to Rosneft at a discount, according to Bloomberg), YETI -0.1% (authorizes new $100 mln share repurchase program)